Ajay Major, MD, MBA
@majorajay
Followers
7K
Following
20K
Media
3K
Statuses
15K
Lymphoma/CLL faculty @CUMedicalSchool. Patient-reported outcomes methodologist & #lymsm quality of life investigator. Founder of https://t.co/kN6qeGFEox.
Denver, CO
Joined November 2011
Announcing the first paper of @TheLancetHaem Commission on Adverse Events, with @BiostatGirl & @GitaThanaMD. We review advances in measuring & reporting newly-described AEs and provide analytic & AE visualization tools for dissemination. . Thread ⬇️ 🧵
3
4
25
RT @pattymondello: I am happy to share our latest article on the controversial FL3B. We found that although most FL3B have comparable outco….
nature.com
Blood Cancer Journal - Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
0
2
0
RT @BiostatGirl: The very serious biostatisticians of #ASHCRTI! #ASHtrainee #ASHcareerdevelopment @ASH_hematology
0
1
0
Dr. @DrSusieC2: "Grants are like blood clots; you're more likely to get one if you've already had one." @ASH_hematology #hemetwitter #ASHCRTI.
0
2
18
0
1
0
Our CRTI group PROs and Poop! 💩 (intersection of patient-reported outcomes and fecal microbiome) #ASHCRTI cc @ASH_hematology
1
3
22
RT @KuykendallMd: When distributing an abstract or manuscript for review by your colleagues, always put like v_14 at the end of the attache….
0
7
0
Dr. @TBuckTN administers his own CRTI 'participant-reported outcome' to illustrate all of the vital components of PRO tools. #ASHCRTI @ASH_hematology
1
0
3
RT @SurbhiSidanaMD: It’s #ASHCRTI week in LaJolla. @ASH_hematology . A week full of redoing study proposals, mentorship and forming life l….
0
12
0
RT @CUHematology: Right around the corner. a continued education event (free CE credits) hosted by the University of Colorado's Division o….
0
2
0
Drs. @DebSiegal & @Lymphoma_Doc giving a great talk this morning about how to run a research team at @ASH_hematology CRTI. #ASHKudos
0
1
27
Day 1 of @ASH_hematology CRTI! Super excited to learn from all these phenomenal investigators and faculty this week. #hemetwitter #ASHKudos
2
2
57
Congratulations to Dr. @uzor_md and this phenomenal group of investigators on execution of this large patient-reported outcomes study! And many thanks for the opportunity to contribute our PRO & financial toxicity methodologic expertise. #gyncsm #gynonc #onctwitter.
Delighted to share our latest research published with @SpringerNature in @SciReports. We show that financial toxicity is a key driver of health-related quality of life among gynecological cancer patients in Nigeria - and identify associated factors.
0
1
3
RT @uzor_md: Delighted to share our latest research published with @SpringerNature in @SciReports. We show that financial toxicity is a ke….
0
8
0
RT @Matt_Cortese: Very proud of my @ClevelandClinic mentor Dr. @BrianHill_MDPhD and former co-fellow Dr Taylor Brooks (@RoswellPark contrib….
0
1
0
RT @FilipGarbicz: Bispecifics in B-ALL - Great.Bispecifics in LBCL - a little disappointing. Do we need trispecifics or bispecific + X comb….
0
4
0
RT @HemSandoval: @majorajay @BloodPortfolio Interesting that RWD in CART do look similar to the pivotal trials, which is totally different….
0
1
0